Concepedia

PiggyBac-mediated Cancer Immunotherapy Using EBV-specific Cytotoxic T-cells Expressing HER2-specific Chimeric Antigen Receptor

Yozo Nakazawa, Leslie E. Huye, Vita S. Salsman, Ann M. Leen, Nabil Ahmed, Lisa Rollins, Gianpietro Dotti, Stephen Gottschalk, Matthew H. Wilson, Cliona M. Rooney

Molecular Therapy · 2011 · 124 citations · 38 references

DOIFull text

Open access

Concepts

References

38

Use of Chemotherapy plus a Monoclonal Antibody against HER2 for Metastatic Breast Cancer That Overexpresses HER2

Dennis J. Slamon, Brian Leyland‐Jones, Steven Shak et al. · New England Journal of Medicine · 2001 · 11.5K citations · Full text

, , +10

Efficacy and Safety of Trastuzumab as a Single Agent in First-Line Treatment of HER2-Overexpressing Metastatic Breast Cancer

Charles L. Vogel · Journal of Clinical Oncology · 2002 · 3K citations

, , +17

Case Report of a Serious Adverse Event Following the Administration of T Cells Transduced With a Chimeric Antigen Receptor Recognizing ERBB2

Richard A. Morgan, James C. Yang, Mio Kitano et al. · Molecular Therapy · 2010 · 2.5K citations · Full text

, , +17

IL-6 programs TH-17 cell differentiation by promoting sequential engagement of the IL-21 and IL-23 pathways

Liang Zhou, Ivaylo I. Ivanov, Rosanne Spolski et al. · Nature Immunology · 2007 · 2.1K citations

, , +16

piggyBac transposition reprograms fibroblasts to induced pluripotent stem cells

Knut Woltjen, Iacovos P. Michael, Paria Mohseni et al. · Nature · 2009 · 1.8K citations · Full text

, , +14